US$ 28.15
difference between sglt2 and glp 1 vs GLP-1: Individualizing Diabetes, Cardiovascular, Renal Outcomes SGLT-2 Inhibitors and GLP-1 Agonists:
Description
GRADE guidelines

J.BaldockP

The future of GLP-1 research As GLP-1s continue to reshape the treatment of type 2 diabetes and obesity (along with an expanding list of potential indications), real-world evidence will be essential for optimizing their use, ensuring access, and tailoring treatments to the individual needs of patients

But the introduction of new oral drugs raises a lot of new questions as well, Cavender says

Tirzepatide is another powerful GLP-1 agonist that has shown promising results in clinical trials for its effectiveness in achieving significant weight loss and improving metabolic health

Endocrinology (2012) 153:346881
